Delivery Order SPE2DR25D1109-SPE2DR26FFH1E
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Prevymis 480 mg tablets in a quantity of seven units, with a contract ceiling value of $4,719.34 and an ultimate completion date of October 7, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Prevymis is an...
- The Defense Logistics Agency awarded a delivery order valued at $4,973.46 to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (7-count packaging), with performance to be completed by December 17, 2025. This non-competitive, firm fixed-price delivery order was awarded on November 25, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used primarily in immunocompromised populations, reflecting the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Prevymis 480 mg tablets (7-count) with a ceiling value of $9,438.70. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is set for ultimate completion by October 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication...
- The Defense Logistics Agency awarded a $4,973.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (7-count units) on October 27, 2025, with completion targeted for November 18, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Prevymis 480 mg tablets in a seven-count package configuration. This firm fixed-price delivery order, valued at $9,946.92, represents a non-competitive award and is scheduled for completion by November 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used in...
- The Defense Logistics Agency awarded a $4,719.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (quantity 7) on June 18, 2025, with an ultimate completion date of July 11, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used to prevent cytomegalovirus infection in immunocompromised patients, representing part of the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Prevymis 480 mg tablets (7-count packages) under a firm fixed-price contract valued at $4,719.34, with completion scheduled for October 6, 2025. This competitively awarded, non-set-aside delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used primarily in immunocompromised...
- The Defense Logistics Agency awarded a $4,719.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count packaging) with an ultimate completion date of November 14, 2025. This non-set-aside, competitively awarded contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Prevymis 480 mg tablets in packages of seven units. This firm fixed-price delivery order, valued at $4,719.34, represents a non-competitive set-aside award and is scheduled for completion by May 15, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Prevymis (letermovir) is an antiviral...
- The Defense Logistics Agency awarded a $14.9K delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Prevymis (480 mg tablets, quantity 7) with a completion date of December 3, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing terms and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to the company's corporate office location in...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFH1EDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,973.46 to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (quantity 7) on December 1, 2025. This non-set-aside, firm fixed price delivery order is scheduled for completion by December 22, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used primarily for cytomegalovirus prophylaxis in immunocompromised patients, supporting the federal healthcare supply chain for military and veteran medical needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and prime vendor for federal medical procurement, AmerisourceBergen maintains a comprehensive portfolio delivering medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The company's selection for this and numerous other federal contracts reflects its demonstrated capability to meet competitive procurement requirements and fulfill critical pharmaceutical supply needs for military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 11/30/25 |